Vega Investment Solutions bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The fund bought 20,102 shares of the company’s stock, valued at approximately $2,583,000.
A number of other hedge funds have also recently added to or reduced their stakes in MKGAF. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in Merck KGaA during the second quarter valued at $942,087,000. Bank of Nova Scotia purchased a new stake in shares of Merck KGaA during the 2nd quarter worth about $281,696,000. Danske Bank A S acquired a new stake in shares of Merck KGaA during the 2nd quarter valued at about $276,535,000. Cullen Capital Management LLC purchased a new position in shares of Merck KGaA in the 2nd quarter valued at about $259,158,000. Finally, Korea Investment CORP acquired a new position in Merck KGaA in the 2nd quarter worth about $239,191,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Stock Performance
Shares of MKGAF stock opened at $163.45 on Tuesday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The business’s 50 day moving average is $162.78 and its two-hundred day moving average is $148.59. The company has a market capitalization of $21.12 billion, a P/E ratio of 24.95 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
